Renal Cancer Research by Sengenics and the University of Leeds Awarded Early Detection Primer Grant Funding from Cancer Research UK
This collaboration will focus on discovery of novel biomarkers for renal cell carcinoma (RCC), with the goal of developing an autoantibody-based early diagnostic test for this disease SINGAPORE (PRWEB) NOVEMBER 26, 2019 Sengenics, the functional proteomics company, together with researchers at the University of Leeds have been awarded an Early Detection[…]
Read more